• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P-糖蛋白相互作用药物的构效关系:其对ATP酶活性影响的动力学特征

Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity.

作者信息

Litman T, Zeuthen T, Skovsgaard T, Stein W D

机构信息

Department of Oncology, Herlev Hospital, University of Copenhagen, Denmark.

出版信息

Biochim Biophys Acta. 1997 Aug 22;1361(2):159-68. doi: 10.1016/s0925-4439(97)00026-4.

DOI:10.1016/s0925-4439(97)00026-4
PMID:9300797
Abstract

We have determined the kinetic parameters for stimulation and inhibition by 34 drugs of the P-glycoprotein ATPase in membranes derived from CR1R12 Chinese hamster ovary cells. The drugs chosen were sets of calmodulin antagonists, steroids, hydrophobic cations, hydrophobic peptides, chemotherapeutic substrates of P-glycoprotein, and some other drugs with lower affinity for P-glycoprotein. We studied how these kinetic parameters correlated with the partition coefficient and the Van der Waals surface area of the drugs. The maximum velocity of ATPase stimulation decreased with surface area and showed a suggestion of a maximum with increasing partition coefficient. The affinity of these drugs for P-glycoprotein showed no significant correlation with partition coefficient but was highly correlated with the surface area suggesting that binding between modulators and P-glycoprotein takes place across a wide interaction surface on the protein.

摘要

我们已经确定了34种药物对源自CR1R12中国仓鼠卵巢细胞的膜中P-糖蛋白ATP酶的刺激和抑制动力学参数。所选择的药物包括钙调蛋白拮抗剂、类固醇、疏水阳离子、疏水肽、P-糖蛋白的化疗底物以及其他一些对P-糖蛋白亲和力较低的药物。我们研究了这些动力学参数如何与药物的分配系数和范德华表面积相关。ATP酶刺激的最大速度随表面积降低,并显示出随分配系数增加而达到最大值的趋势。这些药物对P-糖蛋白的亲和力与分配系数无显著相关性,但与表面积高度相关,这表明调节剂与P-糖蛋白之间的结合发生在蛋白质上广泛的相互作用表面。

相似文献

1
Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity.P-糖蛋白相互作用药物的构效关系:其对ATP酶活性影响的动力学特征
Biochim Biophys Acta. 1997 Aug 22;1361(2):159-68. doi: 10.1016/s0925-4439(97)00026-4.
2
Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity.
Biochim Biophys Acta. 1997 Aug 22;1361(2):169-76. doi: 10.1016/s0925-4439(97)00027-6.
3
Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.多药耐药中国仓鼠卵巢细胞中P-糖蛋白ATP酶活性的表征
Biochem J. 1995 Jun 1;308 ( Pt 2)(Pt 2):381-90. doi: 10.1042/bj3080381.
4
Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet.结合的Hoechst 33342与ATP酶催化位点的接近程度表明P-糖蛋白的药物结合位点位于细胞质膜小叶内。
Biochemistry. 2002 Apr 9;41(14):4744-52. doi: 10.1021/bi0120897.
5
Structure-activity relationship of P-glycoprotein substrates and modifiers.
Eur J Pharm Sci. 2000 Nov;12(1):31-40. doi: 10.1016/s0928-0987(00)00177-9.
6
Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.线性和环状肽作为P-糖蛋白的底物和调节剂:肽结合及其对药物转运和蓄积的影响
Biochem J. 1998 Aug 1;333 ( Pt 3)(Pt 3):621-30. doi: 10.1042/bj3330621.
7
The ATPase and ATP-binding functions of P-glycoprotein--modulation by interaction with defined phospholipids.P-糖蛋白的ATP酶及ATP结合功能——与特定磷脂相互作用的调节作用
Eur J Biochem. 1998 Aug 15;256(1):170-8. doi: 10.1046/j.1432-1327.1998.2560170.x.
8
Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.多药耐药相关P-糖蛋白ATP酶的竞争性和非竞争性抑制——多部位模型的进一步实验证据
Eur J Biochem. 1997 Mar 1;244(2):664-73. doi: 10.1111/j.1432-1033.1997.00664.x.
9
Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.通过其ATP酶活性揭示的疏水肽、细胞毒性药物和化学增敏剂在共同的P-糖蛋白药效基团上的竞争。
J Biol Chem. 1996 Feb 9;271(6):3163-71. doi: 10.1074/jbc.271.6.3163.
10
Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.多药耐药转运蛋白P-糖蛋白对细胞毒性药物和逆转剂具有不同但相互作用的结合位点。
Biochem J. 1998 Jul 15;333 ( Pt 2)(Pt 2):351-8. doi: 10.1042/bj3330351.

引用本文的文献

1
Elucidating the Complex Structural and Molecular Mechanisms Driving P-Glycoprotein-Mediated Transport of Cardiac Glycosides.阐明驱动P-糖蛋白介导的强心苷转运的复杂结构和分子机制。
Int J Mol Sci. 2025 Aug 13;26(16):7813. doi: 10.3390/ijms26167813.
2
Cryo-EM of human P-glycoprotein reveals an intermediate occluded conformation during active drug transport.人P-糖蛋白的冷冻电镜研究揭示了活性药物转运过程中的一种中间封闭构象。
Nat Commun. 2025 Apr 16;16(1):3619. doi: 10.1038/s41467-025-58561-4.
3
Differing temperature dependencies of functional homologs zebrafish Abcb4 and human ABCB1.
斑马鱼Abcb4和人类ABCB1功能同源物不同的温度依赖性
Front Pharmacol. 2024 Aug 6;15:1426040. doi: 10.3389/fphar.2024.1426040. eCollection 2024.
4
Structure-ATPase Activity Relationship of Rhodamine Derivatives as Potent Inhibitors of P-Glycoprotein CmABCB1.若丹明衍生物作为P-糖蛋白CmABCB1强效抑制剂的结构-ATP酶活性关系
ACS Med Chem Lett. 2024 Jan 19;15(2):287-293. doi: 10.1021/acsmedchemlett.3c00526. eCollection 2024 Feb 8.
5
Drug-Induced Conformational Dynamics of P-Glycoprotein Underlies the Transport of Camptothecin Analogs.药物诱导的 P-糖蛋白构象动力学是喜树碱类似物转运的基础。
Int J Mol Sci. 2023 Nov 7;24(22):16058. doi: 10.3390/ijms242216058.
6
P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport.P-糖蛋白(ABCB1)——弱偶极相互作用为理解别构调节剂的识别、结合和转运提供了关键。
Cancer Drug Resist. 2023 Jan 1;6(1):1-29. doi: 10.20517/cdr.2022.59. eCollection 2023.
7
Ligand's Partition to the Lipid Bilayer Should Be Accounted for When Estimating Their Affinity to Proteins.在估算配体与蛋白质的亲和力时,应考虑配体分配到脂质双层的情况。
Molecules. 2023 Mar 31;28(7):3136. doi: 10.3390/molecules28073136.
8
Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients.预测非酒精性脂肪性肝炎患者药物药代动力学的改变及药物不良反应风险
Acta Pharm Sin B. 2023 Jan;13(1):1-28. doi: 10.1016/j.apsb.2022.08.018. Epub 2022 Aug 28.
9
The human proton pump inhibitors inhibit rifampicin efflux and macrophage-induced rifampicin tolerance.人质子泵抑制剂抑制利福平外排和巨噬细胞诱导的利福平耐受。
Proc Natl Acad Sci U S A. 2023 Feb 14;120(7):e2215512120. doi: 10.1073/pnas.2215512120. Epub 2023 Feb 10.
10
Interaction of a Homologous Series of Amphiphiles with P-glycoprotein in a Membrane Environment-Contributions of Polar and Non-Polar Interactions.膜环境中一系列两亲物与P-糖蛋白的相互作用——极性和非极性相互作用的贡献
Pharmaceutics. 2023 Jan 3;15(1):174. doi: 10.3390/pharmaceutics15010174.